Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
08/2012
08/16/2012CA2825964A1 Forms of rifaximin and uses thereof
08/16/2012CA2825028A1 Heterocyclic compounds as pi3 kinase inhibitors
08/16/2012CA2824101A1 N-[3-(5-amino-3,3a,7,7a-tetrahydro-1h-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as bace1 and/or bace2 inhibitors
08/15/2012EP2487176A1 Macrocyclic integrase inhibitors for use in the treatment of feline immunodeficiency virus
08/15/2012EP2487175A1 Pharmaceutical product containing aromatic heterocyclic compound
08/15/2012EP2487160A1 Synthesis of Enone Intermediate
08/15/2012EP2486023A1 Potent conjugates and hydrophilic linkers
08/15/2012EP2485731A1 Heterocyclic compounds useful as pdk1 inhibitors
08/15/2012EP1976855B1 1-aza-3,7-dioxabicyclo[3.3.0]octane compounds and their use as pro-fragrances
08/15/2012CN102639538A Polymorphous forms III and IV of n-benzoyl staurosporine
08/15/2012CN102639537A Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof
08/15/2012CN102639536A Anhydrate forms of a pyridine derivative
08/15/2012CN102639532A Fused triazole amines as P2X7 modulators
08/15/2012CN102633812A Oxazolone quinazoline derivatives as well as preparation method and application thereof
08/15/2012CN102633716A Bicyclic inhibitors of mek and methods of use thereof
08/15/2012CN102633583A Method of using oligonucleotide for chiral drug resolution
08/15/2012CN101421279B Imidazo compounds
08/14/2012US8242104 Benzoxazepin P13K inhibitor compounds and methods of use
08/09/2012WO2012105521A1 Externally-used drug for treating skin disorder and method for producing same
08/09/2012WO2012103959A1 Process for making everolimus
08/09/2012US20120202989 Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximin
08/09/2012US20120202988 Process for the preparation of rapamycin derivatives
08/09/2012US20120202927 Preparing and dispersing surface-modified colour pigments
08/09/2012US20120202821 Conformationally constrained, fully synthetic macrocyclic compounds
08/09/2012US20120202805 PI3K (delta) SELECTIVE INHIBITORS
08/09/2012US20120202804 Fused aminodihydro-oxazine derivatives
08/09/2012US20120202803 N-[3-(5-amino-3,3a,7,7a-tetrahydro-1h-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as bace1 and/or bace2 inhibitors
08/09/2012US20120202792 Antimicrobial Compounds and Methods of Making and Using the Same
08/09/2012US20120202790 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
08/09/2012US20120202785 Heterocyclic compounds and methods of use
08/09/2012US20120202690 Herbicidal compounds
08/09/2012CA2825786A1 Externally-used drug for treating skin disorder and method for producing same
08/08/2012EP2484672A1 Nitrogen-containing heterocyclic compound and salt thereof, and bactericide for agricultural and horticultural use
08/08/2012EP2484667A1 Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same
08/08/2012EP2483279A1 New maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody
08/08/2012EP2483278A1 Benzoxazepin pi3k inhibitor compounds and methods of use
08/08/2012EP2483271A1 Pyrazoline dione derivatives as nadph oxidase inhibitors
08/08/2012EP2483267A1 Evaporable organically semiconductive material and use thereof in an optoelectronic component
08/08/2012EP2482660A1 Composition and method for controlling arthropod pests
08/08/2012EP2114158B1 3-substituted-[1,2,3]benzotriazinone compounds for enhancing glutamatergic synaptic responses
08/08/2012EP1831226B1 Chiral tetracyclic compounds inducing interferon biosynthesis
08/08/2012CN102627663A Preparation method of fluorine-containing pyridine boric acid
08/08/2012CN102627658A Organic compounds
08/08/2012CN101384604B Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives
08/08/2012CN101243068B Compounds for the treatment of multi-drug resistant bacterial infections
08/07/2012US8236958 Polymorphic forms of a GABAA agonist
08/02/2012WO2012102387A1 Pyrazole derivative and pest control agent
08/02/2012WO2012102360A1 Morphinan derivative
08/02/2012WO2012101029A1 Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
08/02/2012WO2012075048A3 Hybrid cyclic libraries and screens thereof
08/02/2012US20120196907 Diazonamide Analogs
08/02/2012US20120196876 (9e)-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2.5).1(14,18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt
08/02/2012US20120196855 Oxygen linked pyrimidine derivatives
08/02/2012US20120196854 Pharmaceutical composition comprising aromatic heterocyclic compound
08/02/2012US20120196848 Thienooxazepine derivative
08/01/2012EP2480557A2 Process for the preparation of rapamycin derivatives
08/01/2012EP2480545A1 Fused triazole amines as p2x7 modulators
08/01/2012EP2032535B1 Spirocyclic nitriles as protease inhibitors
08/01/2012EP1405852B1 Diamine derivatives
08/01/2012CN102625808A Spirocyclic amide derivatives
08/01/2012CN102617729A Tacrolimus immunogen, anti-tacrolimus specific antigen and tacrolimus detection reagent
08/01/2012CN102617599A Macrocyclic compound and application thereof
08/01/2012CN102617598A 5-substituted benzospirooxazine photochromic compound and synthesis method thereof
08/01/2012CN102617597A Modification method for substituting 2' site alkoxy group of spirooxazine compound
08/01/2012CN102617596A Dimeric sesquiterpene compound Hippolide I, its preparation method and its purpose
08/01/2012CN102617595A Preparation method of fluoroquinolone antibacterial medicament marbofloxacin
08/01/2012CN102617580A Vasopressin V1a Antagonists
07/2012
07/31/2012US8232291 Heterocyclic aromatic compounds useful as growth hormone secretagogues
07/31/2012CA2539909C 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo(2,3-c) pyridin-2-ylmethyl) pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes
07/31/2012CA2489965C Pharmaceutical compositions for the treatment of diseases related to neurotrophines
07/26/2012WO2012100179A1 Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives
07/26/2012WO2012098387A1 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors
07/26/2012WO2012048129A3 Inhibitors of polo-like kinase
07/26/2012US20120190862 Methods for Preparing Diazonamides
07/26/2012US20120190848 Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives
07/26/2012US20120190709 Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof
07/26/2012US20120190675 Azaspirohexanones
07/26/2012US20120190654 Novel bicyclic urea compounds
07/26/2012CA2814014A1 Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives
07/25/2012EP2479169A1 Synthesis of Enone Intermediate
07/25/2012EP2477994A1 Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, preparation and use thereof
07/25/2012EP2477993A1 Substituted clavulanic acid
07/25/2012EP1270557B1 Ethylenediamine derivatives
07/25/2012CN102612518A Nitrogen-containing condensed heterocyclic compounds for oleds
07/25/2012CN102603770A Elimination of heterogeneous or mixed cell population in tumors
07/25/2012CN102603731A New quinolone derivative
07/25/2012CN102093387B Crystal compound of 4,5,6,7-tetrahydro-isoxazolo[5,4-c]pyridine-3-alcohol-hydrate
07/24/2012US8227594 Antiviral nucleosides
07/24/2012US8227482 Forms of rifaximin and uses thereof
07/19/2012WO2012096832A2 Hdac inhibiting derivatives of camptothecin
07/19/2012US20120184734 Substituted polycyclic carbamoylpyridone derivative
07/19/2012US20120184566 Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, preparation and use thereof
07/19/2012US20120184565 Compounds for the reduction of beta-amyloid production
07/19/2012US20120184543 Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof
07/19/2012US20120184537 [1,4]-benzodiazepines as vasopressin v2 receptor antagonists
07/19/2012US20120184516 sGC Stimulators
07/19/2012US20120183954 Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
07/19/2012US20120183577 Compositions useful as inhibitors of protein kinases
07/19/2012US20120183496 Inhibitors of hepatitis c virus polymerase
07/18/2012EP1608648B1 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 220